Clinical Trials Browser

NCT04074135 2026-02-24

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

von Hippel-Lindau Disease, Pancreatic Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

NCT04924075 2026-02-24

MK-6482-015

Phase 2 Recruiting

322 enrolled 1 FDA

CNSEndocrine

von Hippel-Lindau Disease, Adenoma, Islet Cell, Paraganglioma, Pheochromocytoma

NCT07167329 2025-09-11

BELIEVE-VHL

Phase 2 Recruiting

100 enrolled

CNSEndocrineGenitourinary

Carcinoma, Renal Cell, von Hippel-Lindau Disease, Paraganglioma, Pheochromocytoma, Neuroectodermal Tumors, Primitive, Hemangioblastoma

NCT03401788 2024-12-03

MK-6482-004

Phase 2 Active not recruiting

50 enrolled 1 FDA

von Hippel-Lindau Disease

NCT03108066 2024-09-24

MK-3795-003

Phase 2 Completed

4 enrolled 11 charts

Genitourinary

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT01967537 2019-11-19

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Phase 2 Completed

341 enrolled 14 charts

EndocrineNET

von Hippel-Lindau Disease, Neuroendocrine Tumors

NCT00052013 2017-03-06

Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584

Phase 2 Completed

11 enrolled

von Hippel-Lindau Disease, Hemangioblastoma

NCT01266070 2017-02-13

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Phase 2 Terminated

6 enrolled 5 charts

CNS

von Hippel-Lindau Disease, Central Nervous System Neoplasms, Hemangioblastoma

NCT00088374 2012-07-27

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Phase 2 Completed

9 enrolled 8 charts

Genitourinary

Carcinoma, Renal Cell, von Hippel-Lindau Disease, Kidney Neoplasms